Estradiol/progesterone

Estradiol/progesterone
Combination of
Estradiol Estrogen
Progesterone Progestogen
Clinical data
Routes of
administration		 Oral
Legal status
Legal status

Estradiol/progesterone (developmental code name TX-001HR, formerly TX-12-001HR) is an oral combination of estradiol, an estrogen, and progesterone, a progestogen, that is under development by TherapeuticsMD for the treatment of menopausal symptoms and endometrial hyperplasia.[1][2] It is currently in phase III clinical trials for these indications.[1] The drug is the first combination of estradiol and progesterone that has been developed for clinical use.[2]

References


This article is issued from Wikipedia - version of the 11/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.